Elimination of corticosteroids after ischemia, by removal of the adrenals,
has been reported to preserve neuronal integrity later. To establish the th
erapeutic potential of this observation, the authors address two questions:
first, whether clinically more relevant steroid manipulations after ischem
ia exert similar protective effects, and second, whether changes in synapti
c functioning occur along with structural alterations. To test this, the au
thors treated animals immediately after hypoxia-ischemia with (1) the stero
id synthesis inhibitor metyrapone, (2) the synthetic glucocorticoid recepto
r agonist dexamethasone, (3) the selective glucocorticoid antagonist RU 384
86, or (4) corticosterone. Metyrapone, but none of the other compounds, att
enuated the occurrence of seizures immediately after ischemia. Twenty-four
hours after hypoxia-ischemia, CAI hippocampal field potentials in response
to stimulation of Schaffer/commissural fibers were found to be reduced. The
attenuation of synaptic transmission was partly prevented by metyrapone. N
one of the other experimental treatments influenced the impaired synaptic f
unction. Gross morphologic analysis revealed no differences in the loss of
neuronal structure between the experimental groups at this time point. Take
n together, these data suggest that metyrapone preserves neuronal functioni
ng despite loss of neuronal structure. The authors tentatively conclude tha
t preventing the ongoing production of steroids shortly after ischemia can
delay and attenuate the appearance of ischemia-related pathology.